Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL9 | O00512 | 1/20 | 0.64 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.61 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.51 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.51 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.51 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenyl Propionic Acid SCHEMBL11756556 | 0.96 | ALDH1A1 (0.60) | BCL9CTNNB1ALDH1A1MAPTKMT2A | |
| SCHEMBL3502645 | 0.89 | BCL9 (0.58) | BCL9CTNNB1ALDH1A1MAPTKMT2A | |
| SCHEMBL12715327 | 0.87 | BCL9 (0.62) | BCL9CTNNB1ALDH1A1MAPTKMT2A | |
| SCHEMBL28476103 | 0.86 | MAPT (0.59) | BCL9CTNNB1ALDH1A1MAPTKMT2A | |
| SCHEMBL16056068 | 0.86 | BCL9 (0.65) | BCL9CTNNB1ALDH1A1MAPTKMT2A | |
| SCHEMBL16056553 | 0.86 | BCL9 (0.61) | BCL9CTNNB1ALDH1A1MAPTKMT2A | |
| SCHEMBL16055480 | 0.86 | BCL9 (0.61) | BCL9CTNNB1ALDH1A1MAPTKMT2A | |
| SCHEMBL17951284 | 0.86 | KMT2A (0.78) | ALDH1A1MAPTKMT2AHTTL3MBTL1 | |
| SCHEMBL16055727 | 0.86 | BCL9 (0.61) | BCL9CTNNB1ALDH1A1MAPTKMT2A | |
| SCHEMBL5729901 | 0.86 | BCL9 (0.65) | BCL9CTNNB1ALDH1A1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110156800-B | Synthesis method of pyrano [3,2-b ] indole-2-ketone compound | 中国药科大学 | 2021-11-26 | — | — | CN | disclosed |
| US-9718763-B2 | Catalytic ester decarbonylation | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2017-08-01 | — | — | US | disclosed |
| US-9718763-B2 | Catalytic ester decarbonylation | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2017-08-01 | — | — | US | disclosed |
| US-20160194276-A1 | CATALYTIC ESTER DECARBONYLATION | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2016-07-07 | — | — | US | disclosed |
| US-20160194276-A1 | CATALYTIC ESTER DECARBONYLATION | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2016-07-07 | — | — | US | disclosed |
| EP-0816916-B1 | Photographic developing composition | EASTMAN KODAK CO (US) | 2004-08-11 | — | — | EP | disclosed |
| US-5942379-A | HIGH SPEED DEVELOPMENT | EASTMAN KODAK COMPANY (US) | 1999-08-24 | — | — | US | disclosed |
| US-5780212-A | DEVELOPER MIXTURE CONTAINING AS CO-DEVELOPER AN N-PHENYL-3-PYRAZOLIDINONE DERIVATIVE HAVING SOLUBILIZING GROUPS INDIRECTLY ATTACHED TO RING(S); WATER SOLUBILITY, EFFICIENCY, NONFOULING | EASTMAN KODAK COMPANY (US) | 1998-07-14 | — | — | US | disclosed |
| EP-0816916-A1 | Photographic developing composition | EASTMAN KODAK COMPANY (US) | 1998-01-07 | — | — | EP | disclosed |
| EP-0098629-A1 | Anti-coagulants of the 4-hydroxycoumarin type, the preparation thereof, and rodenticidal compositions (baits) comprising such anti-coagulants | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1984-01-18 | — | — | EP | disclosed |
| US-4278762-A | MEASURING HYDROLYSIS OF TRIPEPTIDE DERIVATIVES | PENTAPHARM AG (CH) | 1981-07-14 | — | — | US | disclosed |
| US-4190574-A | CHROMOPHORE- OR FLUORESCENT-SUBSTITUTED OLIGOPEPTIDE | PENTAPHARM A.G. (CH) | 1980-02-26 | — | — | US | disclosed |
| US-4070245-A | Substrate for the quantitative determination of proteolytic enzymes | PENTAPHARM A.G. (CH) | 1978-01-24 | — | — | US | disclosed |
| US-4016042-A | SYNTHETIC OLIGOPEPTIDE CONTAINING A CHROMOGENIC OR FLUORESCENT GROUP SPLIT OFF BY PROTEOLYTIC ENZYMES | PENTAPHARM A.G. (CH) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160194276-A1 | CATALYTIC ESTER DECARBONYLATION | DECR1, C1S, CBR3 | BCL9 3704/4885CTNNB1 1404/4885ALDH1A1 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.